Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease.
Takahashi H, Xia P, Cui J, Talantova M, Bodhinathan K, Li W, Saleem S, Holland EA, Tong G, Piña-Crespo J, Zhang D, Nakanishi N, Larrick JW, McKercher SR, Nakamura T, Wang Y, Lipton SA.
Takahashi H, et al. Among authors: nakamura t.
Sci Rep. 2016 Feb 12;6:20750. doi: 10.1038/srep20750.
Sci Rep. 2016.
PMID: 26867695
Free PMC article.
No abstract available.